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Purpose: The aim of this work was to prepare nimodipine-loaded alginate-chitosan beads for sustained 
drug release. 
Methods: Nimodipine-loaded alginate-chitosan beads were prepared by ionic gelation method using 
various combinations of chitosan and Ca
2+
 as cations and alginate as anion. The swelling ability and in 
vitro drug release characteristics of the beads were studied at pH 1.2 and 6.8. Infra-red (IR) 
spectrometry, scanning electron microscopy (SEM), differential scanning calorimetry (DSC), x-ray 
diffraction (XRD), and atomic absorption spectroscopy (AAS) were also applied to investigate the 
physicochemical characteristics of the drug in bead formulations.  
Results: The surface morphology, size, and drug loading of the beads varied with increase in the 
concentration of chitosan and calcium chloride in the gelation medium. The swelling ability of the beads 
in different pH media was dependent on the presence of a polyelectrolyte complex in the beads and the 
pH of the media. Both calcium alginate beads and the beads treated with chitosan failed to release the 
drug at pH 1.2 over the period of study. On the other hand, at pH 6.8, calcium alginate beads released 
approx. 96 % of drug in 6 h, but treatment of the beads with chitosan lowered drug release to 73 %. 
Drug release mechanism was either “anomalous transport” or “case-II transport”. Data from 
characterisation studies indicate that there was no significant change in the physical state of the drug in 
the bead formulations.  
Conclusion: Although nimodipine-loaded alginate beads showed poor sustained release 
characteristics, modification with chitosan yielded beads that exhibited sustained drug release. 
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Alginate is a natural biopolymer which forms 
a hydrogel in the presence of divalent cations 
such as Ca
2+ 
[1]. The inert environment within 
the biopolymer network of alginates allows for 
the entrapment of a wide range of 
substances [2]. Much attention has been 
given in recent years to the use of chitosan-
alginate polyelectrolyte complex in controlled 
drug delivery [3]. The use of chitosan has 
been reported in the literature for coating 
alginate beads in order to alter the diffusion 
rate of the encapsulated substances and also 
as an additive for the bulk modification of the 
bead structure [4].  
 
Nimodipine (NM) is isopropyl-2-methoxyethyl-
1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5 
-pyridine dicarboxylate, a dihydropyridine 
calcium antagonist. It has a short half-life of 
1-2 h, and the usual oral dose is 30 to 60 mg 
to be taken 2 to 4 times a day. Thus, 
nimodipine is a suitable candidate for oral 
sustained release drug delivery. In this work, 
the effect of calcium ion and chitosan in the 
coagulation fluid on drug release 
characteristics as well as the release 
mechanism were evaluated. Also, the 
physical state of the drug in the beads and its 







The following materials were used as 
received: sodium alginate (low viscosity; 
viscosity of 2% solution 25 
o
C, ≈ 250 cps, 
from SNAP Natural and Alginate Products 
Limited, Ranipet, India); chitosan (85% 
degree of deacetylation, molecular weight > 
10
3
 kD, from India Sea Foods, Cochin, India); 
calcium chloride dihydrate (Qualigens, 
Mumbai, India); and di-sodium hydrogen 
phosphate anhydrous, potassium di-
hydrogen phosphate, sodium acetate, 
potassium chloride, sodium hydroxide, 
dichloromethane, ethanol (99%), hydrochloric 
acid and glacial acetic acid (all from Merck, 
Mumbai, India). Nimodipine B.P. was 
obtained as a gift from Cipla Limited, 
Mumbai, India. 
 
Preparation of nimodipine-loaded calcium 
alginate beads  
 
Nimodipine was dissolved in dichloromethane 
and then slowly dispersed in sodium alginate 
solution with constant stirring for 3 h, as per 
the composition outlined in Table 1. The 
dispersion was added drop-wise to the 
gelation medium (either 2% or 5% w/v 
calcium chloride) using a 5 ml hypodermic 
syringe fitted with a 21
o
-gauge needle and 
with the gelation medium stirred constantly at 
room temperature (25 
o
C). The beads were 
left to cure in the gelation medium for 4 h, 
taken out, washed with distilled water twice 
and then dried at 30 
o
C in a dust free 
chamber until they attained constant weight. 
Two drug : sodium alginate ratios – 1:3 and 
1:4 – were used in the preparation of the 
beads. The beads were labeled CAB. 
 
In another batch labeled ACB-I, drug-loaded 
alginate-chitosan beads were prepared using 
chitosan solution (0.5% or 0.75% w/v) 
containing calcium chloride (2% or 5% w/v) 
as the gelation medium. The vehicle of the 
chitosan solution was 3% v/v acetic acid and 
the pH of the medium was adjusted to 4.5 ± 
0.1 with 0.1M sodium hydroxide. Drug: 
polymer ratio was varied as described above. 
The gelation medium was prepared 2h before 
use. The beads were prepared and 
recovered as described earlier. 
 
In another variation, ACB-II beads were 
prepared as for ACB-I except that the cure 
time was 2 h instead of 4 h. In a further 
variation, multilayered (MB) beads prepared 
as for ACB-II (at a chitosan concentration of 
0.75%) were first treated with sodium alginate 
solution (0.1 % w/v) and then cured in 
calcium chloride solution (1% w/v) for 30 min 
at room temperature (25 
o
C).  
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Table 1: Composition of nimodipine-loaded calcium alginate (Nm-CAB), alginate-chitosan (Nm-ACB-I & II) 
and multilayer (Nm-MB) beads 
 
Gelation medium Post-gelation treatment  Formulation Code 














A0/A0a 2 - - - - - 
A1/A1a 2 0.5 - - - - 
A2/A2a 2 0.75 - - - - 
A3/A3a 2 - 0.5 1 - - 
A4/A4a 2 - 0.75 1 - - 
A5/A5a 2 - 0.75 1 0.1 1 
FA0/ FA0a 5 - - - - - 
FA1/FA1a 5 0.5 - - - - 
FA2/FA2a 5 0.75 - - - - 
FA3/FA3a 5 - 0.5 1 - - 
FA4/FA4a 5 - 0.75 1 - - 
FA5/FA5a 5 - 0.75 1 0.1 1 
 
     Note: Sodium alginate was 5 %w/v in all formulations; CH = chitosan; CaCl2 = calcium chloride;  
   SA =    sodium alginate 
 
Morphological characterisation and size 
of beads 
 
The beads were examined by a scanning 
electron microscope (JEOL JSM – 5200, 
Japan) operating between 5 - 24 kV.  The 
specimens were mounted on a metal stub 
(with double-sided adhesive tape) and coated 
under vacuum with gold in nitrogen 
atmosphere prior to observation. The bead 
size of all the formulations was determined by 
optical microscopy. At least 100 beads were 
analyzed for each preparation and the mean 
particle size was calculated.  
 
Determination of drug loading  
 
An accurately weighed sample (10 mg) of 
drug-loaded bead was pulverized using 
mortar and pestle, incubated in 10 ml 0.02M 
phosphate buffer (pH 6.8) at room 
temperature for 24 h for complete digestion 
and the drug extracted with ethanol (99% 
v/v). The solution was filtered through a filter 
disc (particle retention: 11µm) and then the 
filtrate was assayed spectrophotometrically 
for drug content at 236nm. The same method 
was utilized to prepare the blank but using 
unloaded beads. All the experiments were 
performed in triplicate. Drug loading or 
incorporation efficiency (%) was calculated 
using the formula in Eq 1. 
Experimental drug loading in % (EL) = L/L0 x 
100  ……… (1) 
where L is the actual drug content of the 




The swelling properties of the calcium 
alginate, alginate-chitosan and alginate-
chitosan multilayer beads were determined in 
buffer solutions of pH 1.2, 4.5, and 6.8, 
respectively, at predetermined time intervals. 
A sample of beads of known weight (10 mg) 
was placed in a Petri dish containing 20 ml of 
the buffer solution and allowed to swell at 
room temperature. At hourly intervals, the 
beads were removed and weighed. The 
weight of the swollen beads was determined 
(after blotting with filter paper to remove 
surface fluid) on an electronic balance 
(AB204-S Mettler Toledo), and thereafter 
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returned to the buffer solution. The swelling 
ratio of the beads was calculated from the 
formula given in Eq 2 [5].  
Swelling ratio= Wt /W0  …………………  (2) 
where Wt is the weight of the swollen beads 
and W0 is the initial weight of the beads.  
 
Determination of calcium content  
 
 The calcium content of blank calcium 
alginate and alginate-chitosan beads, as well 
as that of nimodipine-loaded beads was 
determined using the procedure of Takka S 
et al
7
. Beads (100mg), accurately weighed, 
were dissolved in 2 ml of concentrated nitric 
acid by boiling. The sample was made up to 
10 ml with 1 %v/v nitric acid and the calcium 
content was determined by atomic absorption 
spectroscopy (Perkin Elmer, model Analysis-
200).   
 
In vitro drug release studies  
 
Each sample for release studies consisted of 
the beads, equivalent to 20 mg of nimodipine, 
and filled into a hard gelatin capsule. Drug 
release studies were carried out, using a 
USP dissolution rate test apparatus type II 
(Electro Lab model TDT- 08L), in 600 ml of 
hydrochloric acid buffer solution (pH 1.2) or 
phosphate buffer solution (pH 6.8) for 4 h and 
6 h, respectively, at 37 ± 0.5°C. The 
dissolution media also contained 0.3 %w/v of 
sodium dodecyl sulphate (SDS) to maintain 
sink conditions for the drug. The apparatus 
was operated at a stirring speed of 100 rpm. 
Five (5) ml of the dissolution medium was 
sampled at predetermined time intervals, and 
replenished with the same quantity of fresh 
dissolution medium on each occasion to keep 
the volume constant. The sample was filtered 
through a filter disc (particle retention: 11µm) 
and analyzed for drug content at 236 nm on a 
spectrophotometer (160-UV-visible Shimadzu 
spectrophotometer). The release kinetics of 
nimodipine from the beads were also 
evaluated using different models, zero order, 
first order, Higuchi, Peppas-Korsmeyer and 
Hixon-Crowell. This assessment was carried 
out with the aid of a program, PCP Disso v 
2.08 (Anant Katkar, Poona College of 
Pharmacy, India).   
 
FT-Infrared spectroscopy  
 
Individual beads/samples were crushed in a 
mortar with a pestle. The crushed material 
was mixed with potassium bromide (Merck IR 
spectroscopy grade) in a 1:100 proportion 
and dried at 40 
o
C. The mixture was 
compressed to a 12 mm semitransparent disk 
by applying a pressure of 10 tons for 2 
minutes. The FTIR spectra over the 
wavelength range 4000 to 400 cm-1 were 
recorded using a FTIR spectrometer (Perkin 
Elmer 1600 series).  
 
Differential scanning calorimetry  
 
Differential scanning calorimetry (DSC) 
nimodipine, sodium alginate, chitosan, as 
well as nimodipine/sodium alginate physical 
mixture (PM1), nimodipine/sodium 
alginate/chitosan physical mixture 
(PM2),nimodipine-loaded calcium alginate 
beads (A0) and alginate-chitosan beads-II 
(A4). The test was carried out using a thermal 
analysis system (Mettler TA 4000), calibrated 
with indium as the standard  and operated in 
the temperature range, 30-400
 o
C. The bead 
sample (5mg) which was heated at 10 
o
C/min 
in an aluminum pan under a nitrogen 
atmosphere using an empty pan as the 
reference. The automatically computed 
onsets of melting point and enthalpy of fusion 
were noted. 
 
X-ray diffraction  
 
X-diffraction patterns of the individual 
materials, physical mixtures and beads were 
obtained with an x-ray diffractometer (Rich 
Seifert, model 3000 P) at 30 kV and 15 mA 
over a range of 10-100 2θ, using Cu Kα 
radiation wavelength of 1.5405 A
o
. In the 
technique, the cavity of the metal sample 
holder of the equipment was filled with 
ground sample powder and then smoothed 
out with a spatula before the test was run. 
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RESULTS 
 
Morphological characteristics and bead 
size 
 
The scanning electron micrograph of a typical 
drug-loaded alginate bead treated with 
chitosan is shown in Fig 1. The beads had a 
spherical shape and showed surface cracks 
probably caused by partial collapsing of the 
polymer network during drying. The mean 
particle size of the beads ranged from 




Figure 1:  Scanning electron micrograph of 




Drug loading was approx. 23 and 18 % for 
formulations in which the drug/polymer ratio 
was 1:3 and 1:4, respectively.  Variation in 
the treatment of the beads did not affect drug 
loading. 
  
Swelling characteristics of nimodipine-
loaded beads 
 
The results of swelling studies, shown in Fig 
2, indicate that swelling varied with the pH of 
the medium. Maximum swelling ratios were 
as high as 2, 14 and 36 in media pH of 1.2, 
4.5 and 6.8, respectively. The beads did not 
show any sign of disintegration in the media 
at pH 1.2 and 4.5 over a period of 8 h. 
However the swelling ratio of the beads at pH 
4.5 was considerably greater than that at pH 
1.2. Treatment of the calcium alginate beads 
with chitosan enhanced swelling at pH of 1.2 
and 4.5. On the other hand, the beads began 




























Figure 2: The swelling characteristics of 
nimodipine beads in various pH media. (Mean ± 
SD; n=3). Key: Blank calcium-alginate beads (S0), 
Drug loaded calcium–alginate beads (A0), Drug 
loaded alginate-chitosan beads prepared by the 
drug polymer dispersion directly dropped in to the 
gelation medium containing a mixture of calcium 
chloride with 0.5% chitosan solution (A1) and 
0.75% chitosan solution (A2), Drug loaded 
alginate-chitosan beads prepared by incubate the 
drug loaded calcium-alginate beads in to the 
gelation medium containing a mixture of calcium 
chloride with 0.5% (w/v) chitosan solution (A3) and 
0.75% (w/v) chitosan solution (A4), Alginate-
chitosan beads (A4) further incubated in 0.1% 
sodium alginate solution (A5). 
 
In vitro drug release of nimodipine 
 
At pH 1.2, there was no discernible release of 
nimodipine from calcium alginate beads and 
those pretreated with chitosan after 4 h.  On 
the other hand, as Fig 3 illustrates, 95.8 % of 
nimodipine was released from the untreated 
beads (formulation A0) at pH 6.8 in 6 h during 
which it completely disintegrated. Following 
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treatment with 0.75% chitosan, yielding 
formulation A4, drug release fell to 75.6 %. 
Further treatment with alginate, resulting in 
formulation A5, slightly reduced drug release 
further to 73.1± 1.69%.  
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Figure 3: Cumulative release of nimodipine in pH 
6.8 phosphate buffer from nimodipine-loaded 
beads (Mean ± S.D.; n=3). Key: As for Fig 2  
 
On subjecting the release data to various 
models, correlation coefficient (r
2
) ranged 
from 0.98 - 0.99 for most of the formulations, 
except for the Higuchi model where was as 
low as 0.94 for some of the formulations. 
Furthermore, in the case of the Peppas-
korsmeyer model, the release kinetics were 
also found to fit the classical power law 
expression, with n values of 0.57 - 0.58 for 
the untreated beads, and 0.87 – 0.93 for the 
treated beads. 
. 
FT-IR spectroscopy  
 
The FT-IR spectra (not displayed) of 
nimodipine alone manifested major peaks in 
the wave number range of 1000 to 1400 cm
-1
, 
indicating the presence of carboxyl and 
carboxylate groups, and C-H stretching, 
appeared at 2981.48 to 2898.38 cm
-1
. Cross-
linking of alginate by Ca
2+
 resulted in a 
decrease in the wave number of the carbonyl 
peak from 1623.7 to 1608.97 cm
−1
. The 
principal peaks of nimodipine were observed 
in the spectra of all the formulations. 
 
Differential scanning calorimetric analysis 
 
Fig 4 shows the DSC thermograms of 
nimodipine alone, the polymers, physical 
mixtures of the polymers and the drug, as 
well as nimodipine-loaded beads. A sharp 
endothermic peak corresponding to the 
melting of crystalline nimodipine was found at 
126.8
 o
C while sodium alginate decomposed 
at 253.6
 o
C with a broad exotherm.
 
The 
degradation exotherm of sodium alginate was 
absent in formulations A0 (CAB) and A4 
(ACB II) beads but an endotherm 
corresponding to the interaction of alginate 





C, respectively. The melting 
endotherm of nimodipine in PM1 (physical 
mixture of nimodipine/sodium alginate), and 
PM2 (nimodipine/sodium alginate/chitosan) 
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Figure 4: DSC thermograms of sodium alginate 
(a), chitosan (b), nimodipine (c), physical mixture 
of nimodipine with sodium alginate (d), physical 
mixture of nimodipine, sodium alginate and 
chitosan (e), nimodipine-loaded alginate beads (f), 
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In the bead formulations, the melting 




C for formulations A0 and A4, 
respectively. 
 
X-ray diffraction (XRD) 
 
The x-ray diffractogram of nimodipine alone, 
the individual polymers, physical mixtures of 
the polymers and the drug, as well as the 
nimodipine-loaded beads are displayed in Fig 
5. Pure nimodipine showed the classical 
diffractogram of the crystalline substance; 
that of sodium alginate indicated the 
presence of a completely amorphous material 
while the diffractogram of chitosan 
manifested a few crystalline peaks of very 
low intensity.  The XRD pattern of the 
physical mixtures showed no changes in the 
crystalline nature of the individual 
components, but their peaks were more 
diffused in bead formulations, possibly due to 
changes in the degree of crystallinity of the 
drug that might have occurred following its 
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Figure 5: X-ray powder diffraction patterns of 
sodium alginate (a), chitosan (b), nimodipine (c), 
physical mixture of nimodipine with sodium 
alginate (d), physical mixture of nimodipine, 
sodium alginate and chitosan (e), nimodipine-
loaded alginate beads (f), and nimodipine-loaded 
alginate beads coated with chitosan (g) 
DISCUSSION 
 
Bead size was not noticeably enhanced 
following treatment of the alginate beads with 
chitosan. Further treatment with alginate also 




At low pH (1.2 and 4.5), bead swelling was 
minimal. This may be attributed to the 
inability of the medium to penetrate the beads 
at pH 1.2, and limited penetration at pH 4.5. 
On the other hand, the pronounced swelling 
of the beads in phosphate buffer (pH 6.8) 
followed by slow disintegration after 7 h might 
have been influenced by certain factors. It 
can be said that in the initial phase of the 
swelling process, the Ca
2+
 ions present in the 
polymannuronate units of alginate are 
exchanged with Na
+
 ions present in the buffer 
solution, which ultimately causes chain 
relaxation and enhances gel formation or 
swelling. In the later stage of the swelling 
process, Ca
2+
 ions bind with the –COO
- 
group 
of the polyglucuronate units and thus form 
the tight egg-box structure which also starts 
to exchange with Na
+
 ions in the buffer 
medium because polyglucuronate sequences 
have a strong auto-cooperative binding of 
Ca
2+
 ions. Increase in the proportion of 
calcium alginate in the drug-loaded beads 
may led to a corresponding increase in the 
amount of Ca
++
, and hence availability of a 
larger number of binding sites for interaction 
with anions.
 
It was observed that the amount 
of calcium ions in formulations (A4, A4a and 
FA4a) decreased when compared with 
formulation A0. This indicates that the 
alginate formed a complex both with calcium 
ions and chitosan [7]. 
 
Poor drug release at pH 1.2 may be 
attributed to the poor swelling of the alginate 
beads at acidic pH due to the inability of the 
dissolution medium to penetrate the beads. 
However, the dissolution medium readily 
penetrated the beads at pH 6.8, easily 
leaching out the drug incorporated in them. 
Treatment of the alginate beads with 
chitosan, and then with alginate, substantially 
Adhiyaman & Basu 
Trop J Pharm Res, October 2009; 8 (5):  440 
reduced drug release. The probable reason is 
that electrostatic interaction between carboxyl 
groups of the alginate and the amino group of 
chitosan produced a compact surface layer 
that reduced both diffusion of fluid into the 
beads and the erosion of the beads.  Drug 
release at pH 6.8 was accompanied by rapid 
swelling and erosion/disintegration of the 
alginate beads. The drug release data for the 
various calcium alginate beads fitted into the 
classical power law expression, and the 
values of n were around 0.6. This indicates 
that drug release from alginate beads 
followed non-Fickian kinetics, due probably to 
rapid swelling and erosion of the beads. The 
release data for alginate-chitosan (Nm-ACB-I 
&II) multilayer beads also fitted well into the 
power law expression, and the values of n 
decreased below 1. It is likely that the 
formation of polyelectrolyte complex 
membrane reduced the initial swelling and 
erosion of the beads and shifted the drug 
release mechanism toward anomalous 
transport or case II transport, indicating that 
the drug was diffusing through the beads at 
the same time as polymer relaxation was 
taking place. Since the release of the drug 
from alginate–chitosan beads exhibited a 
small time lag, the release data were fitted 
into the modified power law expression, and 
this yielded excellent linearity. Consequently, 
it can be concluded that the drug release 
mechanism was anomalous diffusion type or 
case II transport. 
 
FT-IR and DSC data indicate there was no 
interaction between nimodipine on the one 
hand, and chitosan and alginate on the other. 
For the DSC results, the slight differences 
observed in the melting endotherms and 
peak intensities may be attributed to 
homogeneous dispersion of the drug in the 
polymers and to variation in drug/polymer 
ratio. The differences observed between the 
XRD patterns of the bead formulations and 
those of the physical mixtures of the drug and 
polymers was probably due to a decrease in 
the degree of crystallinity of the drug, which 






The study demonstrates that while alginate 
beads incorporating nimodipine exhibited 
comparatively rapid drug release at intestinal 
pH (6.8), treatment with chitosan alone or 
together with alginate lowered drug release. 
The bead formulations thus afford an option 
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